Gastroenterology
Scott Snapper, professor at Harvard Medical School, talks about IBD and therapeutic possibilities based on the manipulation of the intestinal microbiota.
Exosome-like nanoparticles derived from plants contain RNAs that regulate gut microbiota composition and impact on the gut barrier function.
In the pathogenesis of IBDs, the gut microbiota plays a key role. Treating gut dysbiosis may be a solutions, so companies are exploring this possibility.
Migrating to a western country alters the intestinal microbiome and provides a key to understanding metabolic diseases such as obesity.
